EMEA (Europe, Middle East and Africa) Pertuzumab Market Report 2017

October 2017 | 105 pages | ID: E1351238833PEN
QYResearch

Abstracts

In this report, the EMEA Pertuzumab market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Pertuzumab for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pertuzumab market competition by top manufacturers/players, with Pertuzumab sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis AG
• Pfizer
• Abnova Corporation
• InvivoGen
• Celltrion
• Biocon Limited
• Bio-Techne

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Human Source
• Animal Source

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Pertuzumab for each application, including

• Hospital
• Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Pertuzumab Market Report 2017

1 PERTUZUMAB OVERVIEW

1.1 Product Overview and Scope of Pertuzumab
1.2 Classification of Pertuzumab
  1.2.1 EMEA Pertuzumab Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Pertuzumab Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Human Source
  1.2.4 Animal Source
1.3 EMEA Pertuzumab Market by Application/End Users
  1.3.1 EMEA Pertuzumab Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Medical Center
1.4 EMEA Pertuzumab Market by Region
  1.4.1 EMEA Pertuzumab Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Pertuzumab (2012-2022)
  1.5.1 EMEA Pertuzumab Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Pertuzumab Revenue and Growth Rate (2012-2022)

2 EMEA PERTUZUMAB COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Pertuzumab Market Competition by Players/Manufacturers
  2.1.1 EMEA Pertuzumab Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Pertuzumab Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Pertuzumab Sale Price by Players (2012-2017)
2.2 EMEA Pertuzumab (Volume and Value) by Type/Product Category
  2.2.1 EMEA Pertuzumab Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Pertuzumab Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Pertuzumab Sale Price by Type (2012-2017)
2.3 EMEA Pertuzumab (Volume) by Application
2.4 EMEA Pertuzumab (Volume and Value) by Region
  2.4.1 EMEA Pertuzumab Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Pertuzumab Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Pertuzumab Sales Price by Region (2012-2017)

3 EUROPE PERTUZUMAB (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Pertuzumab Sales and Value (2012-2017)
  3.1.1 Europe Pertuzumab Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Pertuzumab Revenue and Growth Rate (2012-2017)
3.2 Europe Pertuzumab Sales and Market Share by Type
3.3 Europe Pertuzumab Sales and Market Share by Application
3.4 Europe Pertuzumab Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Pertuzumab Sales Volume by Countries (2012-2017)
  3.4.2 Europe Pertuzumab Revenue by Countries (2012-2017)
  3.4.3 Germany Pertuzumab Sales and Growth Rate (2012-2017)
  3.4.4 France Pertuzumab Sales and Growth Rate (2012-2017)
  3.4.5 UK Pertuzumab Sales and Growth Rate (2012-2017)
  3.4.6 Russia Pertuzumab Sales and Growth Rate (2012-2017)
  3.4.7 Italy Pertuzumab Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Pertuzumab Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PERTUZUMAB (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Pertuzumab Sales and Value (2012-2017)
  4.1.1 Middle East Pertuzumab Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Pertuzumab Revenue and Growth Rate (2012-2017)
4.2 Middle East Pertuzumab Sales and Market Share by Type
4.3 Middle East Pertuzumab Sales and Market Share by Application
4.4 Middle East Pertuzumab Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Pertuzumab Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Pertuzumab Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Pertuzumab Sales and Growth Rate (2012-2017)
  4.4.4 Israel Pertuzumab Sales and Growth Rate (2012-2017)
  4.4.5 UAE Pertuzumab Sales and Growth Rate (2012-2017)
  4.4.6 Iran Pertuzumab Sales and Growth Rate (2012-2017)

5 AFRICA PERTUZUMAB (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Pertuzumab Sales and Value (2012-2017)
  5.1.1 Africa Pertuzumab Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Pertuzumab Revenue and Growth Rate (2012-2017)
5.2 Africa Pertuzumab Sales and Market Share by Type
5.3 Africa Pertuzumab Sales and Market Share by Application
5.4 Africa Pertuzumab Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Pertuzumab Sales Volume by Countries (2012-2017)
  5.4.2 Africa Pertuzumab Revenue by Countries (2012-2017)
  5.4.3 South Africa Pertuzumab Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Pertuzumab Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Pertuzumab Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Pertuzumab Sales and Growth Rate (2012-2017)

6 EMEA PERTUZUMAB MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Novartis AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pertuzumab Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis AG Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Pertuzumab Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Abnova Corporation
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Pertuzumab Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Abnova Corporation Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 InvivoGen
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Pertuzumab Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 InvivoGen Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Celltrion
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Pertuzumab Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Celltrion Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Biocon Limited
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Pertuzumab Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Biocon Limited Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bio-Techne
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Pertuzumab Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bio-Techne Pertuzumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 PERTUZUMAB MANUFACTURING COST ANALYSIS

7.1 Pertuzumab Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pertuzumab

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pertuzumab Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pertuzumab Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PERTUZUMAB MARKET FORECAST (2017-2022)

11.1 EMEA Pertuzumab Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Pertuzumab Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Pertuzumab Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Pertuzumab Price and Trend Forecast (2017-2022)
11.2 EMEA Pertuzumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Pertuzumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Pertuzumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Pertuzumab Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Pertuzumab Sales Forecast by Type (2017-2022)
11.7 EMEA Pertuzumab Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pertuzumab
Figure EMEA Pertuzumab Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Pertuzumab Sales Volume Market Share by Type (Product Category) in 2016
Figure Human Source Product Picture
Figure Animal Source Product Picture
Figure EMEA Pertuzumab Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Pertuzumab by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure EMEA Pertuzumab Market Size (Million USD) by Region (2012-2022)
Figure Europe Pertuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Pertuzumab Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Pertuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Pertuzumab Revenue (Million USD) Status and Forecast by Countries
Figure Africa Pertuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Pertuzumab Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Pertuzumab Sales Volume and Growth Rate (2012-2022)
Figure EMEA Pertuzumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Pertuzumab Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Pertuzumab Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Pertuzumab Sales Share by Players (2012-2017)
Figure 2016 Pertuzumab Sales Share by Players
Figure 2017 Pertuzumab Sales Share by Players
Figure EMEA Pertuzumab Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Pertuzumab Revenue (Million USD) by Players (2012-2017)
Table EMEA Pertuzumab Revenue Share by Players (2012-2017)
Table 2016 EMEA Pertuzumab Revenue Share by Players
Table 2017 EMEA Pertuzumab Revenue Share by Players
Table EMEA Pertuzumab Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Pertuzumab Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Pertuzumab Sales Share by Type (2012-2017)
Figure Sales Market Share of Pertuzumab by Type (2012-2017)
Figure EMEA Pertuzumab Sales Market Share by Type (2012-2017)
Table EMEA Pertuzumab Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Pertuzumab Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pertuzumab by Type in 2016
Table EMEA Pertuzumab Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Pertuzumab Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Pertuzumab Sales Share by Application (2012-2017)
Figure Sales Market Share of Pertuzumab by Application (2012-2017)
Figure EMEA Pertuzumab Sales Market Share by Application in 2016
Table EMEA Pertuzumab Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Pertuzumab Sales Share by Region (2012-2017)
Figure Sales Market Share of Pertuzumab by Region (2012-2017)
Figure EMEA Pertuzumab Sales Market Share in 2016
Table EMEA Pertuzumab Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Pertuzumab Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Pertuzumab by Region (2012-2017)
Figure EMEA Pertuzumab Revenue Market Share Regions in 2016
Table EMEA Pertuzumab Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Pertuzumab Revenue and Growth Rate (2012-2017)
Table Europe Pertuzumab Sales (K Pcs) by Type (2012-2017)
Table Europe Pertuzumab Market Share by Type (2012-2017)
Figure Europe Pertuzumab Market Share by Type in 2016
Table Europe Pertuzumab Sales (K Pcs) by Application (2012-2017)
Table Europe Pertuzumab Market Share by Application (2012-2017)
Figure Europe Pertuzumab Market Share by Application in 2016
Table Europe Pertuzumab Sales (K Pcs) by Countries (2012-2017)
Table Europe Pertuzumab Sales Market Share by Countries (2012-2017)
Figure Europe Pertuzumab Sales Market Share by Countries (2012-2017)
Figure Europe Pertuzumab Sales Market Share by Countries in 2016
Table Europe Pertuzumab Revenue (Million USD) by Countries (2012-2017)
Table Europe Pertuzumab Revenue Market Share by Countries (2012-2017)
Figure Europe Pertuzumab Revenue Market Share by Countries (2012-2017)
Figure Europe Pertuzumab Revenue Market Share by Countries in 2016
Figure Germany Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Pertuzumab Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Pertuzumab Sales (K Pcs) by Type (2012-2017)
Table Middle East Pertuzumab Market Share by Type (2012-2017)
Figure Middle East Pertuzumab Market Share by Type (2012-2017)
Table Middle East Pertuzumab Sales (K Pcs) by Applications (2012-2017)
Table Middle East Pertuzumab Market Share by Applications (2012-2017)
Figure Middle East Pertuzumab Sales Market Share by Application in 2016
Table Middle East Pertuzumab Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Pertuzumab Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Pertuzumab Sales Volume Market Share by Countries in 2016
Table Middle East Pertuzumab Revenue (Million USD) by Countries (2012-2017)
Table Middle East Pertuzumab Revenue Market Share by Countries (2012-2017)
Figure Middle East Pertuzumab Revenue Market Share by Countries (2012-2017)
Figure Middle East Pertuzumab Revenue Market Share by Countries in 2016
Figure Saudi Arabia Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Pertuzumab Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Pertuzumab Sales (K Pcs) by Type (2012-2017)
Table Africa Pertuzumab Sales Market Share by Type (2012-2017)
Figure Africa Pertuzumab Sales Market Share by Type (2012-2017)
Figure Africa Pertuzumab Sales Market Share by Type in 2016
Table Africa Pertuzumab Sales (K Pcs) by Application (2012-2017)
Table Africa Pertuzumab Sales Market Share by Application (2012-2017)
Figure Africa Pertuzumab Sales Market Share by Application (2012-2017)
Table Africa Pertuzumab Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Pertuzumab Sales Market Share by Countries (2012-2017)
Figure Africa Pertuzumab Sales Market Share by Countries (2012-2017)
Figure Africa Pertuzumab Sales Market Share by Countries in 2016
Table Africa Pertuzumab Revenue (Million USD) by Countries (2012-2017)
Table Africa Pertuzumab Revenue Market Share by Countries (2012-2017)
Figure Africa Pertuzumab Revenue Market Share by Countries (2012-2017)
Figure Africa Pertuzumab Revenue Market Share by Countries in 2016
Figure South Africa Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Table Novartis AG Pertuzumab Basic Information List
Table Novartis AG Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis AG Pertuzumab Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Pertuzumab Revenue Market Share in EMEA (2012-2017)
Table Pfizer Pertuzumab Basic Information List
Table Pfizer Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Pertuzumab Sales Market Share in EMEA (2012-2017)
Figure Pfizer Pertuzumab Revenue Market Share in EMEA (2012-2017)
Table Abnova Corporation Pertuzumab Basic Information List
Table Abnova Corporation Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abnova Corporation Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abnova Corporation Pertuzumab Sales Market Share in EMEA (2012-2017)
Figure Abnova Corporation Pertuzumab Revenue Market Share in EMEA (2012-2017)
Table InvivoGen Pertuzumab Basic Information List
Table InvivoGen Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure InvivoGen Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure InvivoGen Pertuzumab Sales Market Share in EMEA (2012-2017)
Figure InvivoGen Pertuzumab Revenue Market Share in EMEA (2012-2017)
Table Celltrion Pertuzumab Basic Information List
Table Celltrion Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celltrion Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Celltrion Pertuzumab Sales Market Share in EMEA (2012-2017)
Figure Celltrion Pertuzumab Revenue Market Share in EMEA (2012-2017)
Table Biocon Limited Pertuzumab Basic Information List
Table Biocon Limited Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biocon Limited Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biocon Limited Pertuzumab Sales Market Share in EMEA (2012-2017)
Figure Biocon Limited Pertuzumab Revenue Market Share in EMEA (2012-2017)
Table Bio-Techne Pertuzumab Basic Information List
Table Bio-Techne Pertuzumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bio-Techne Pertuzumab Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bio-Techne Pertuzumab Sales Market Share in EMEA (2012-2017)
Figure Bio-Techne Pertuzumab Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pertuzumab
Figure Manufacturing Process Analysis of Pertuzumab
Figure Pertuzumab Industrial Chain Analysis
Table Raw Materials Sources of Pertuzumab Major Manufacturers in 2016
Table Major Buyers of Pertuzumab
Table Distributors/Traders List
Figure EMEA Pertuzumab Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Pertuzumab Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Pertuzumab Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Pertuzumab Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Pertuzumab Sales Market Share Forecast by Region (2017-2022)
Table EMEA Pertuzumab Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Pertuzumab Revenue Market Share Forecast by Region (2017-2022)
Table Europe Pertuzumab Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Pertuzumab Sales Market Share Forecast by Countries (2017-2022)
Table Europe Pertuzumab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Pertuzumab Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Pertuzumab Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Pertuzumab Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Pertuzumab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Pertuzumab Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Pertuzumab Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Pertuzumab Sales Market Share Forecast by Countries (2017-2022)
Table Africa Pertuzumab Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Pertuzumab Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Pertuzumab Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Pertuzumab Sales Market Share Forecast by Type (2017-2022)
Table EMEA Pertuzumab Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Pertuzumab Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources